Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-18F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study

By afschroeder • May 14, 2026

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer EJ, Udelson JE, Bateman TM. Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-¹⁸F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study. J Nucl Cardiol. 2026 May 12:102741. doi: 10.1016/j.nuclcard.2026.102741. Epub ahead of print. PMID: 42128226.

Tags: Cardiac PET, Cardiology/Epi, Cedars Sinai DoM, coronary artery disease, F-18 flurpiridaz, myocardial perfusion imaging, Obesity, Publications, radiotracers

Prevalence, Progression, and Prognosis of Heart Stress In the Community: Implications for Heart Failure Prevention

Cai A, Liu L, Feng Y, Zhou Y, Li L, Bozkurt B, Januzzi JL, Lam CSP, Fonarow GC, Pandey A, Zhou Z, Cheng Y, Bayes-Genis[...]

Massive Pulmonary Embolism Presenting as Recurrent Cardiac Arrest: Successful Resuscitation and Thrombolysis in a 74-Year-Old Male

Dave PR, Khan MZ, Higgins JR. Massive Pulmonary Embolism Presenting as Recurrent Cardiac Arrest: Successful Resuscitation and Thrombolysis in a 74-Year-Old Male. Cureus. 2026 Apr[...]

30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease

Yadav PK, Vahl TP, Thourani VH, Latib A, Chehab BM, Rinaldi M, Makkar R, Rogers JH, Rodés-Cabau J, Singh G, Gössl M, Sorajja P, Reardon[...]